VEA
ASMB icon

Virtus ETF Advisers’s Assembly Biosciences ASMB Stock Holding History

Virtus ETF Advisers’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-1,230
Closed -$243K – 357
2020
Q3 		$243K Sell
1,230
-168
-12% -$42.3K 0.13% 272
2020
Q2 		$391K Buy
1,398
+2
+0.1% +$467 0.19% 203
2020
Q1 		$248K Sell
1,396
-204
-13% -$43.7K 0.1% 252
2019
Q4 		$393K Buy
1,600
+146
+10% +$26.9K 0.06% 266
2019
Q3 		$172K Sell
1,454
-81
-5% -$12.3K 0.03% 269
2019
Q2 		$248K Buy
+1,535
New +$292K 0.05% 276

Other funds holding ASMB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
AIM
Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

Virtus ETF Advisers's ASMB Position: Q4 2020 in Review

Virtus ETF Advisers sold out of Assembly Biosciences (ASMB) in Q4 2020, closing a stake of 1,230 shares — an estimated $243K sold.

Virtus ETF Advisers first reported a position in ASMB in Q2 2019 and held it in 6 quarters. The position peaked at $393K in Q4 2019. 109 funds tracked by Wall St. Rank hold ASMB as of Q4 2020.

  • Virtus ETF Advisers reported no remaining Assembly Biosciences position as of Q4 2020 after selling out during the quarter.
  • Virtus ETF Advisers sold 1,230 Assembly Biosciences shares in Q4 2020, an estimated $243K.
  • Virtus ETF Advisers first reported a position in Assembly Biosciences in Q2 2019 and held it in 6 quarters.
  • Virtus ETF Advisers's Assembly Biosciences position peaked at $393K in Q4 2019.
  • 109 funds tracked by Wall St. Rank held Assembly Biosciences as of Q4 2020.

Based on Virtus ETF Advisers's 13F filing for Q4 2020, filed 12 Feb 2021.